Centre amends NDCTR-2019 to ease rules for approval of new drugs & investigational new drugs: Gireesh Babu, New Delhi Friday, January 23, 2026, 08:00 Hrs [IST] The Union health mi ...

The initiative could tackle the first-mover disadvantage some CDMOs believe deters early customers, but leaders at companies ...

It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

Ulanqab Kema’s growth is underpinned by a multifaceted strategic advantage. Its location in Ulanqab, Inner Mongolia, provides direct access to high-quality raw material inputs and cost-effective ...

HANGZHOU CITY, ZHEJIANG PROVINCE, CHINA, January 20, 2026 /EINPresswire.com/ -- The global fine chemicals industry is ...

Here's a novel pathway to a more sustainable planet: carbo-loading for the public good. In a new study published in Nature ...

In A Nutshell Personalized AI “health agents,” virtual drug trials, and automated compliance tools could quietly speed up ...

Europe’s easing of AI and data rules could unlock faster innovation. Tech experts detail the AI use cases most likely to ...

The EMA validation of T-DXd with pertuzumab could change the standard of care for HER2-positive metastatic breast cancer in ...

Ubiquitination is a crucial post-translational modification process where the small protein ubiquitin is attached to target proteins, marking them for degradation or altering their function. This ...

The case analysis explores whether India’s anti-money laundering framework is effective despite comprehensive legislation. Courts have adopted a tougher stance, but enforcement gaps and evolving ...